Matilda Florentin

2.3k total citations
73 papers, 1.7k citations indexed

About

Matilda Florentin is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Matilda Florentin has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 27 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Matilda Florentin's work include Lipoproteins and Cardiovascular Health (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers) and Pharmacology and Obesity Treatment (10 papers). Matilda Florentin is often cited by papers focused on Lipoproteins and Cardiovascular Health (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers) and Pharmacology and Obesity Treatment (10 papers). Matilda Florentin collaborates with scholars based in Greece, United Kingdom and United States. Matilda Florentin's co-authors include Moses Elisaf, Evangelos Liberopoulos, Dimitri P. Mikhailidis, Anthony S. Wierzbicki, Michael S. Kostapanos, Dimitri P. Mikhailidis, Haralampos Milionis, Georgé Liamis, Vasilios G. Athyros and Sotirios Giannopoulos and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Matilda Florentin

68 papers receiving 1.7k citations

Peers

Countries citing papers authored by Matilda Florentin

Since Specialization

Citations

This map shows the geographic impact of Matilda Florentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilda Florentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilda Florentin more than expected).

Fields of papers citing papers by Matilda Florentin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matilda Florentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilda Florentin. The network helps show where Matilda Florentin may publish in the future.

Co-authorship network of co-authors of Matilda Florentin

This figure shows the co-authorship network connecting the top 25 collaborators of Matilda Florentin. A scholar is included among the top collaborators of Matilda Florentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matilda Florentin. Matilda Florentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches	Cancers	Konstantinos Arvanitakis, Georgios Kalopitas et al.	5
2	Structural radial artery modifications following transradial access: Mechanisms, clinical implications, and preventive strategies	World Journal of Cardiology	Dimitrios Nikas, Evangelos Liberopoulos et al.	0
3	Association of Alkaline Phosphatase with Cardiovascular Disease in Patients with Dyslipidemia: A 6-Year Retrospective Study	Journal of Cardiovascular Development and Disease	Matilda Florentin, Evangelos Liberopoulos et al.	0
4	Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels—Potent Clinical Implications	Pharmaceuticals	Georgé Liamis, Evangelos Liberopoulos et al.	14
5	Familial hypercholesterolemia and its manifestations: Practical considerations for general practitioners	Kardiologia Polska	Panagiotis Anagnostis, Christina Antza et al.	3
6	Egg Consumption, Cardiovascular Disease and Cardiometabolic Risk Factors: The Interaction with Saturated Fatty Acids. Results from the ATTICA Cohort Study (2002–2012)	Nutrients	Matina Kouvari, Matilda Florentin et al.	8
7	Hyponatremia in Patients with Heart Failure beyond the Neurohormonal Activation Associated with Reduced Cardiac Output: A Holistic Approach	Cardiology	Georgé Liamis, Katerina Κ. Naka et al.	2
8	Hemostatic Factors and the Metabolic Syndrome	Current Vascular Pharmacology	Michael S. Kostapanos, Matilda Florentin et al.	39
9	Microalbuminuria: A Neglected Cardiovascular Risk Factor in Non-diabetic Individuals?	Current Pharmaceutical Design	Eirini Lioudaki, Matilda Florentin et al.	8
10	Colesevelam Plus Rosuvastatin 5 mg/Day Versus Rosuvastatin 10 mg/Day Alone on Markers of Insulin Resistance in Patients with Hypercholesterolemia and Impaired Fasting Glucose	Metabolic Syndrome and Related Disorders	Matilda Florentin, Evangelos Liberopoulos et al.	12
11	Antiplatelet Drugs: What Comes Next?	UCL Discovery (University College London)	Matilda Florentin, Moses Elisaf et al.	1
12	“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses	Current Vascular Pharmacology	Dimitri P. Mikhailidis, Moses Elisaf et al.	156
13	The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia	Current Medical Research and Opinion	Matilda Florentin, Evangelos Liberopoulos et al.	23
14	Emerging options in the treatment of dyslipidemias: a bright future?	Expert Opinion on Emerging Drugs	Matilda Florentin, Evangelos Liberopoulos et al.	12
15	Vitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk?	Current Vascular Pharmacology	Panagiotis Anagnostis, Vasilios G. Athyros et al.	48
16	Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia	Current Vascular Pharmacology	Matilda Florentin, Moses Elisaf et al.	25
17	A patient with new-onset hypercholesterolemia	Journal of clinical lipidology	Evangelos Liberopoulos, Matilda Florentin et al.	1
18	Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes	Expert Opinion on Pharmacotherapy	Matilda Florentin, Evangelos Liberopoulos et al.	19
19	Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study	Expert Opinion on Pharmacotherapy	Matilda Florentin, Evangelos Liberopoulos et al.	12
20	The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?	Expert Opinion on Therapeutic Targets	Asterios Karagiannis, Dimitri P. Mikhailidis et al.	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact